We established a reliable and robust signature rooted in four AMGs (HPRT1, CTNS, SHMT1, SLC38A7) based on publicly available databases and systematically evaluated its predictive power for OS and progression-free survival (PFS) in patients with HNSCC. This evidence concerns the gene SHMT1 and head and neck squamous cell carcinoma.